Pain and physical functioning in neuropathic pain: a systematic review of psychometric properties of various outcome measures by Meeta, Poonam et al.
For Peer Review
 
 
 
 
 
 
Pain and physical functioning in neuropathic pain: a 
systematic review of psychometric properties of various 
outcome measures 
 
 
Journal: Pain Practice 
Manuscript ID: PPR-2014-0207.R1 
Manuscript Type: Review 
Keywords: Assessment,Pain, Nerve Pain, Polyneuropathy 
  
 
 
Pain Practice
Pain Practice
For Peer Review
1 
 
ABSTRACT 
Introduction: A range of outcome measures across various domains are used to evaluate change 
following an intervention in clinical trials on chronic Neuropathic pain (NeP). However, in order to 
capture a real change in the variable of interest, the psychometric properties of a particular measure 
should demonstrate appropriate methodological quality. Various outcome measures in the domains 
of pain and physical functioning have been used in the literature for NeP, for which individual 
properties (e.g., reliability/validity) have been reported. To date, there is no definitive synthesis of 
evidence on the psychometric properties of those outcome measures, thus the aim of this 
systematic review was to evaluate the methodological quality [COnsensus based Standards for the 
selection of health status Measurement INstruments (COSMIN) guidelines] of studies that evaluated 
psychometric properties of pain and physical functioning outcome measures used for NeP.  
Methods: Specific MeSH/key-words related to three areas (pain and/or physical functioning, 
psychometric properties, and NeP) were used to retrieve relevant studies (English language) in key 
electronic databases (Medline (Ovid), CINAHL (EBSCO), Scopus, AMED and Web of Science) from 
database inception- July 2012. Articles retrieval/screening and quality analysis (COSMIN) were 
carried out by two independent reviewers.  
Results: 24 pain and 37 physical functioning outcome measures were identified, varying in 
methodological quality from Poor-Excellent.  
Conclusion: Although a variety of pain and physical functioning outcome measures have been 
reported in the literature, few have demonstrate methodologically strong psychometric properties. 
Thus, future research is required to further investigate the psychometric properties of existing pain 
and physical functioning outcome measures used for clinical and research purposes.  
Keywords: neuropathic pain; systematic review; pain; physical function; outcome measures; 
psychometric properties; reliability; validity; responsiveness  
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1. INTRODUCTION 
Neuropathic pain (NeP) is defined by the International Association for the Study of Pain’s 
Neuropathic Pain Special Interest Group (NeuPSIG) as “pain arising as a direct consequence of a 
lesion or disease affecting the somatosensory system”.1 A range of assessment guidelines have been 
developed from the Initiative on Methods, Measurement and Pain Assessment in Clinical Trials 
(IMMPACT),2 the European Federation of Neurological Societies (EFNS),3 and the NeuPSIG4 for NeP 
clinical trials and for clinical practice. These guidelines advocate a range of measures for assessing 
the core domains of pain, quality of life, mood, sleep, and functional capacity (physical, cognitive, 
emotional, and social). This notwithstanding, a variety of outcome measures are available for the 
above stated domains.2 In order to evaluate the applicability of these measures, a systematic review 
of psychometric properties of available outcome measures used in published trials may provide a 
useful basis for selecting the best measurement instrument for a specific purpose.5,6 
Individual assessment of psychometric properties of available outcome measures is important.7,8 
As part of this, in reviewing the evidence on available outcome measures, it is important to assess 
the methodological quality of those studies that investigated psychometric properties.9 While in 
clinical practice adoption of outcome measures will depend on feasibility of use (speed, ease of use, 
and limited need for an overly sophisticated instrument),10 emphases should be also be given to 
measures which are proven to be reliable, valid, and responsive/interpretable for a given population. 
Pain remains a leading cause of disability at the individual level, associated with functional losses 
as well as mood disturbances.11 Thus the focus of this systematic review will be in evaluating the 
psychometric properties of various outcome measures used in the domains of pain and physical 
functioning in NeP. On examination of the literature, a number of outcome measures have been 
identified in which have been used to measure pain intensity and physical function in NeP 
trials;5,7,8,12 however, there is limited conclusive evidence on their psychometric properties. Use of 
reliable and valid outcome measures can help to better evaluate the patient’s outcomes in terms of 
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pain and physical functioning, enabling better management, including the earliest appropriate 
management to minimize risks of co morbidities and disabilities.  
Existing evidence on the psychometric properties of pain and physical functioning outcome 
measures used in NeP trials have not previously been systematically reviewed. The aim of this 
systematic review was to systematically review and identify the gaps in literature for the evaluated 
psychometric properties (reliability, validity, responsiveness, and interpretability) of identified 
outcome measures for ‘pain and physical functioning’ as recommended by the IMMPACT guidelines 
in NeP population. This review involved a systematic search of the literature. The findings of the 
current study may assist in outlining the effective intervention strategies for patients with NeP. The 
objectives of this systematic review were: 
• Systematically review and identify the type of established psychometric properties for the 
identified outcome measures quantifying pain and physical functioning in neuropathic pain 
populations. 
• Evaluate the methodological quality of the included studies investigating the psychometric 
properties of the identified outcome measures in the domain of pain and physical 
functioning in neuropathic pain populations in accordance with the Consensus-based 
Standards for the selection of Health Measurement Instruments (COSMIN) checklist with 4-
point scale. 
2. METHOD 
2.1 Information sources 
A systematic search was conducted following the Preferred Reporting Items for Systematic 
reviews and Meta-Analyses (PRISMA) guidelines. The following electronic databases were searched: 
Ovid Medline, CINAHL, Scopus, AMED, and Web of Science (WOS) (from database inception to 31st 
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July 2012). The search update engine from the available databases was activated in order to be 
familiar with the new searches in the current field, since the original search. 
2.2 Search strategy 
The key words and MESH headings in three broad areas (pain and/or physical functioning 
outcome measures, psychometric properties, and NeP) were used in the development of a search 
strategy (Table I). Several strategies were used to develop a comprehensive list of keywords/MeSH 
terms/subject headings representing each area. For outcome measures, all pain and physical 
functioning outcome measures that were used in clinical trials of NeP were chosen. For 
psychometric properties, we chose the standardised terminologies used by the COSMIN frame 
work.6 For the terms relating to NeP, MESH terms/ key words indexed for neuropathy, neuralgia, 
and neurodynia were used. Words within each theme were combined with OR and across themes 
with AND. This search strategy was amended for different databases as necessary. 
Insert Table I about here. 
2.3 Study selection 
Articles identified in the search underwent a series of screening processes. Firstly, duplicate 
articles were removed. Two reviewers (PM and LC) independently selected and screened articles for 
potential eligibility at the title and abstract stages. Full text articles of all potentially eligible abstracts 
were retrieved for application of the eligibility criteria. Disagreements between the reviewers 
regarding inclusion of individual studies were discussed during a consensus meeting and, when 
unresolved, were resolved by discussion with other reviewers (PH, CC, and GDB). References of the 
selected papers were further explored for relevant articles. 
2.4 Eligibility criteria 
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Cross sectional studies and longitudinal cohort studies, which included at least one 
assessment of a psychometric property of a pain or functional outcome measure in a NeP population 
(Nep as defined by the Clinical Resource Efficiency Support Team- CREST)13 were included. The 
adopted search strategy revealed two distinct categories of evaluations: one intended for screening 
or diagnosis, and the other developed to measure outcomes. Since the focus of this review was to 
investigate the psychometric properties of tools used to measure changes in the status of either pain 
or functional outcomes over time: screening or diagnostic tools were excluded. Studies published as 
case report, editorial, or reviews were also excluded. Only articles published in the English language 
and on humans were selected. 
2.5 Data extraction and synthesis 
A systematic approach to data extraction was carried out by independent reviewers (PM and 
LC/ PH/ CC/ GDB), with equal number of articles randomly distributed among the team members. 
Each member extracted the data from the allotted articles, which were then checked for accuracy, 
with consensus meetings and opinions from other reviewers to resolve any disagreements. The 
following data were collected and tabulated from each of the included articles: study reference, 
participant characteristics, outcome measures studied, and type of psychometric properties tested 
(reliability and/or validity) (Table II). Further summary of identified outcome measures with their 
published psychometric properties and COSMIN grading were synthesized (Table IV & V). Results 
from excellent and good methodological quality studies based on COSMIN criteria (as stated in Table 
VI) were used to formulate recommendations for acceptable psychometric properties scores (for 
definitions of acceptable, good and excellent scores see Table VI). 
2.6 Methodological quality of individual studies reporting on psychometric properties 
Whereas a variety of tools are available to measure the methodological quality of studies that 
report on scale development and assessed psychometric properties, the Consensus-based Standards 
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for the selection of Health Measurement Instruments (COSMIN)6 checklist; developed by an 
international group of experts, is unique and preferred because it allows for individual assessment of 
each psychometric domain within a study. 
The COSMIN checklist14 (Table III) consists of ‘A to J’ nine boxes (Internal consistency-.Box A; 
Reliability- Box B; Measurement error- Box C; Content validity- Box D; Structural validity- Box E; 
Hypotheses testing- Box F; Cross-cultural validity- Box G; Criterion validity- Box H; Responsiveness- 
Box I; Interpretability- Box J), with 5–18 items concerning methodological standards for how each 
measurement property should be assessed. According to COSMIN guidelines, the methodological 
quality of a study is considered adequate if all items in a box (A to J) were considered adequate. For 
this, each item was scored on a 4-point rating scale (i.e., ‘‘poor’’, ‘‘fair’’, ‘‘good’’, or ‘‘excellent’’). The 
primary investigator (PM) independently scored all articles and the results were discussed and 
consensus obtained with each relevant team member. Methodological quality was determined using 
the ‘lowest rating score’6 achieved by any item for the representative psychometric property. 
Therefore, if one criterion for any property scored ‘poor’, the methodological quality for that 
particular property was rated as ‘poor’ overall, irrespective of the scores that other criteria achieved. 
Disagreements regarding COSMIN scoring were resolved by discussion between reviewers. 
Reviewers were not blinded to the journal affiliation or authors of the included articles. 
Insert Table III about here. 
3. RESULTS 
Figure 3.1 illustrates the study selection process. The search resulted in 10,913 articles. After 
accounting for duplicate removal, title screening, and abstract screening, 80 articles were identified 
and retrieved as potentially eligible for the review. While checking the eligibility of full text articles, a 
further 16 articles were excluded from the review as two articles were editorial papers; two were 
commentary papers; five articles were based on cancer pain; three papers were PhD publications; 
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and for the remaining four, full text article were not available. Thus total of 64 articles satisfied our 
eligibility criteria and were included in this review. 
Insert Figure I about here 
3.2 Characteristics of included studies 
In total, 64 studies reporting 61 different outcome measures were identified. The included 
studies evaluated the psychometric properties of pain outcome domains (n=24) and physical 
function outcome domains (n= 37), (Table II). For the 24 pain intensity outcome measures, fifteen 
(63%), measures were patient-reported/self-reported measures, and the rest nine (37%) were the 
therapist/ clinician completed measures. For the 37 physical function outcome measures, seventeen 
(46%) measures were patient-reported/ self-reported measures i.e. symptomatic assessment 
(subjective), nine (24%) measures were performance based measures, and the rest of the eleven 
(30%) measures were therapist completed measures i.e. symptoms and signs (subjective and 
objective testing). The synthesis of results per/ outcome measure, their published psychometric 
properties, and quality assessment scores for studies, are detailed in Table IV and V. Data on the 
characteristics of the study population and sample population were extracted on the interpretability 
and generalizability boxes provided by the COSMIN checklist. Information regarding the sample size 
and gender distribution is reported in Table II. 
Insert Table II about here. 
3.2.1 Pain intensity outcome measures 
Pain domain outcomes (Table II, and IV) included: Brief Pain Inventory Scale for Diabetic 
Peripheral Neuropathy;15 Complex Regional Pain Syndrome Severity Score;16 Diabetes Symptom 
Checklist Type-2;17 Foot Function Index (pain subscale);18 Italian Neuropathic Pain Symptom 
Inventory;19 McGill Pain Questionnaire;20 modified Toronto Clinical Neuropathy Score;21 Neuropathic 
Pain Scale;22-24 Neuropathic Pain Sensory Inventory;25,26 0-10 Numerical Rating Scale;27 Neuropathy 
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Total Symptom Score-6;28 0-10 point Pain Intensity- Numerical Rating Scale;29 Pain Quality 
Assessment Scale;30,31 Portuguese version of the Neuropathic Pain Symptoms Inventory;32 
Quantitative Sensory Testing (hot and cold pain threshold);33-35 Sensory evaluation with Semmens-
Weinstein Monofilaments;36 Short-form McGill Pain Questionnaire-2;37 Spanish Neuropathic Pain 
Symptom Inventory;38 Toronto Clinical Scoring System;39 Total Neuropathy Score;40 Trauma Related 
Neuronal Dysfunction Symptoms Inventory;41 Utah Early Neuropathy Scale;42 Visual Analog Scale;43 
and Zoster Brief Pain Inventory.44,45 
3.2.2 Physical functioning outcome measures  
The range of physical functioning outcome measures was equally extensive, and included 
(Table II, and V): Alderson-McGall Hand Function questionnaire;46 Barthel Index;47 Berg Balance 
Measure;48 Brief Pain Inventory Facial;49 Charcot-Marie-Tooth disease Neuropathy score;50,51 
Charcot-Marie-Tooth disease Neuropathy Score-2;52 Disabilities of Arm, Shoulder and Hand 
Questionnaire;53-56 Deambulation Index;47 Dellon-modified Moberg pick-up test;57 Facial Disability 
Index;58 Functional Dexterity test;59 Human Activity Profile;60 INCAT The Overall Disability Sum 
Score;61 Inflammatory neuropathy Sensory Score;62 Levine-Katz Questionnaire;56 Michigan Hand 
Outcome Questionnaire;53 modified Neuropathy Disability Score;63 10-Meter walking test;48,64 Nine-
Hole Peg test;64 Neuropathy Impairment Score;51 Overall Disability Sum Score;65 Overall Neuropathy 
Limitations Scale;64,66 Patient Evaluation Measure;53 Physical Performance Measures (6 minute walk 
test, Timed up and go test);67 Questionnaire Rising and Sitting down;68 Radboud skills 
Questionnaire;69 short form Screening of Activity Limitation and Safety Awareness Scale;70,71 Step 
Activity Monitor;72 Step Activity Monitor (4 min walk test);73 Sheehan Disability Scale;74 Sollerman 
Hand function test;59 Turkish version of the Boston Questionnaire;75 Ulnar Neuropathy at the Elbow 
Questionnaire;76 12-Item Multiple Sclerosis Walking Scale;77 Walking Stairs Questionnaire;68 Work 
stimulation tasks (knob turn, Linear motion, and Lever arm);78 and Zoster Impact Questionnaire.45 
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3.3 Methodological quality of studies evaluating psychometric properties of pain intensity and 
physical functioning outcome measures  
3.3.1 Reliability 
The majority of the instruments included in our review were not tested for all psychometric 
properties listed on COSMIN checklist. Forty four of the sixty four studies (68%) assessed various 
forms of reliability (Internal consistency, inter-rater reliability, intra-rater reliability, test-retest 
reliability, and measurement error) and showed a mixed methodological quality of evidence 
(excellent/good/fair/poor), when evaluated on COSMIN (Table IV and V). The key results for 
reliability showed that the BPI-DPN, and the SF-MPQ2 have excellent (α> 0.90) internal consistency. 
The mTCNS has good internal consistency (α= 0.81- 0.90), inter-rater reliability, and intra-rater 
reliability (ICC or К= 0.81-0.90). The hot and cold pain thresholds on the QST have good inter-rater 
and test-retest reliability (ICC or К= 0.81-0.90). The Spanish NPSI has excellent internal 
consistency(α> 0.90) with good test-retest reliability(ICC or К= 0.81-0.90). Measurement error was 
the least reported form of reliability, and the TRNDSI had good test-retest reliability (ICC or К= 0.81-
0.90) and measurement error (see Table IV). These measures with excellent and good psychometric 
properties scores also scored good/excellent on the COSMIN checklist (as according to COSMIN 
criteria stated in Table VI). 
3.3.2 Validity 
Validity was the more frequently tested psychometric property, in forty nine of sixty four 
studies (76%), there was face/content validity, structural validity, construct validity, 
criterion/concurrent validity, convergent validity, discriminative validity, hypothesis testing, and 
responsiveness. Similar to the findings for reliability, mixed methodological quality evidence 
(excellent/good/fair/poor) was found when evaluated on COSMIN (Table IV and V). The key results 
for validity showed that the NPSI, the SALSA, and the UNEQ have excellent content validity as there 
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were no concerns raised by the patients or experts regarding the wording of questionnaires, and 
thus no further modifications were advised. The UENS has the best criterion validity followed by the 
HAP and the mNDS. Approximately one third of the studies (18/49, 36%) evaluated responsiveness 
form of validity. The NPS has excellent responsiveness followed by the 0-10 PI NRS, and the ODSS. 
Also the studies showing these evidences were of excellent/good methodological quality on the 
COSMIN checklist (as according to COSMIN criteria stated in Table VI). 
Insert Table IV and V about here. 
4. Discussion 
To our knowledge, this is the first systematic review to evaluate the evidence for the 
psychometric properties of pain and physical functional outcome measures used in assessment in 
NeP conditions, and to identify the methodological quality of the studies investigating the 
psychometric properties of various outcome measures. A total of 61 different outcome measures 
were identified related to the domains of pain and physical functioning. In this systematic review, 
while most of the studies have shown good/excellent evidence of reliability and validity of the used 
scales, only few are considered ‘excellent to good’ in terms of their methodological quality. Our 
review identified acceptable reliability and validity (for a few key properties) for the mTCNS, the 
TRNDI, the 0-10 PI NPS, the QST, the SALSA, the Spanish NPSI, the ODSS, the SF-MPQL, the UNEQ, 
the UENS, the HAP, the mNDS, the NDS and the BPI-DPN. 
The available studies investigating the psychometric property of reliability were rated in 
varying methodological quality from ‘poor’ to ‘excellent’ on the COSMIN checklist. However, the 
majority of studies showed similar methodological shortcomings. In this review, smaller sample sizes 
were found to be associated with the majority of inconsistent results. According to COSMIN 
guidelines,6 a sample size of ≥100 is considered to be an adequate/ excellent sample size, given the 
need for precision in the overall estimates; these estimates are based on the power 0.80.79, 25 A 
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sample size of 50 provides a 0.70 power (level of significance being 0.05), while 100 has a power of 
0.94.25 
In the current systematic review, many outcome measures seem promising for different 
domains of reliability and validity (according to COSMIN criteria stated in Table VI), as the FFI, the 
NTSS-6, the AMHFQ, the DASH, the HAP, the ISS, the MHQ, the PEM, the SDS, the TBQ, the UNEQ, 
and the Walk-12 scales have ‘moderate’ (α> 0.71-0.80) to ‘excellent’ (α> 0.90) published grades for 
internal consistency. However, when the methodological quality of the studies were evaluated on 
COSMIN, these were graded of ‘poor/fair’ quality because of the small sample size. These findings 
are consistent with those of a recent systematic review on outcome measures in neck pain, where 
smaller sample sizes frequently led to poorer results.80 This current review recommends that future 
research on a larger sample size (n= ≥100, as recommended by COSMIN) is needed to improve the 
quality of research on these measures. 
Validity was the most frequently evaluated psychometric property in both pain and physical 
functioning outcome domains. The majority of these studies demonstrated unsatisfactory (poor/fair 
scores) results on COSMIN. The main reasons for this were inconsistencies in the following areas: 
smaller sample sizes; hypotheses were not formulated; and expected direction/magnitude of 
correlations was not stated in advance. Other common findings were a lack of information about 
reporting of missing items, and measures adopted to handle missing data. Though these two items 
did not contribute to the overall ‘poor’ grading on the COSMIN, it is expected that studies of ‘good’ 
methodological quality should report this construct, as a high number of missing items can introduce 
bias.  
A further interesting finding of this review was that responsiveness was the least frequently 
studied psychometric property for the included pain and physical functioning outcome measures. 
There were a total of 18 studies which published the findings on responsiveness and only three 
scales- the NPS, the 0-10 PI NRS and the ODSS proved satisfactory methodological quality on 
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COSMIN. The remaining measures were graded ‘fair to poor’, and all the above stated shortcomings 
(small sample size, un-reporting of missing items, vagueness about how the missing data were 
handled, not well formulated hypothesis etc.) equally contributed to the inconsistent results for the 
studies reporting on this property. 
In the current systematic review, there were few measures identified which had promising 
psychometric properties for key variables: the mTCNS (good internal consistency, inter-rater and 
intra-rater reliability and criterion validity); the TRNDSI, and the ZBPI (good test-retest reliability); 
the NPSI (excellent face/content validity); the 0 to 10 PI NRS (good responsiveness); the QST- pain 
threshold (good intra-rater and test-retest reliability); the NPS (excellent responsiveness); and the 
SALSA (excellent internal consistency and content validity), and were supported by a “excellent to 
good’ methodological quality on the COSMIN checklist. The future use of these measures can be 
recommended based on their proven psychometric properties; however, it is imperative that other 
remaining psychometric properties of these outcome measures should also be established. 
We also identified a list of instruments which showed their best methodological quality for 
few psychometric properties on COSMIN, but at the same time good methodological quality 
evidence was lacking for other properties: the TCSS (good construct validity, but poor inter and intra-
rater reliability); the Short-form MPQ- 2 (excellent internal consistency, but fair construct validity 
and responsiveness); the HAP (good criterion validity, with poor internal consistency and 
responsiveness and fair hypothesis testing); the ODSS (good responsiveness but fair inter-rater and 
intra-rater reliability and construct validity); the UNEQ (excellent content validity, fair test-retest 
reliability, and poor internal consistency, construct validity, and responsiveness); the TBQ (good 
construct validity, fair test-retest reliability, and poor internal consistency); the UENS (excellent 
criterion validity, with poor inter-rater reliability and responsiveness); and the BPI-DPN (excellent 
internal consistency and discriminative validity, fair construct validity and poor criterion validity). 
Since study methodology may influence results for psychometric properties, it is recommended that 
Page 12 of 76
Pain Practice
Pain Practice
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
13 
 
further evaluation of these psychometric properties with studies of improved methodological quality 
should be carried out. 
Limitations 
Firstly, it is acknowledged that ‘Neuropathic Pain conditions’ is an umbrella term which 
covers a range of different conditions such as diabetic neuropathy, trigeminal neuralgia, and post 
herpetic neuralgia.81 For the search strategy, MESH terms/ key words indexed for neuropathy, 
neuralgia, and neurodynia were used to be as inclusive as possible. It is acknowledged that each 
condition could have been separately searched, and that such an approach may have lessened the 
chances of missing studies. 
Secondly, psychometric properties such as reliability and validity, including responsiveness, 
are sub classified into various forms such as internal consistency, inter-rater/test retest reliability, 
content validity, minimal important difference, and standard error of measurement etc.82 For the 
current search strategy, keywords in three broader areas (reliability and/or, validity and/or, and 
responsiveness) were used rather than individual sub classified keywords. However, since these 
broader terms are the most commonly used to denote the various forms of psychometric properties, 
it is anticipated that the majority of studies would have been selected. 
Lastly, for this systematic review, multidisciplinary, international consensus-based 
methodological quality reporting guidelines, COSMIN, were followed for rating the quality of 
included studies of psychometric properties. The COSMIN checklist has well developed data 
extraction forms with detailed instructions for completion. The 4-point rating scale classifies each 
assessment of a measurement property as ‘excellent, good, fair, or poor’, based on the scores of the 
items in the corresponding COSMIN box. The methodological quality of a study is considered 
adequate if all items in a box (A to J) are considered adequate. However, frequently not all items in a 
box are scored adequate, and it is not feasible to provide overall definitive grade for each 
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psychometric property; thus no decisions can be drawn for the methodological quality of the studies 
based purely on COSMIN findings. 
Conclusion 
In this review we evaluated the evidence for psychometric properties of 61 unique outcome 
measures identified to assess pain and physical functioning outcome domains in trials of NeP 
conditions. We have presented extensive data which demonstrate the psychometric properties of 
these available outcome measures, and recommend the use of the mTCNS, the TRNDSI, the ZBPI, the 
NPSI, the 0 to 10 PI NRS, the QST- pain threshold, and the NPS to detect changes in pain intensity 
and physical functions. We found that important information regarding the methodological quality 
of the majority of studies demonstrating these psychometric properties is lacking or is of poor 
quality. Since NeP is a multi-disabling condition with significant associated morbidity, usage of 
quality evidenced pain and physical functional measures is a key recommendation for future 
research in NeP intervention studies. It appears that despite representing these measures in many 
studies of NeP, the methodological quality for most of the measures is not strong enough to 
recommend their use based on their psychometric properties. Thus, good quality future research is 
required to further investigate the psychometric properties of identified outcome measures used for 
clinical and research purposes. 
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FIGURE LEGENDS 
Figure I Flow diagram summarising study selection process 
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Table I Search Strategy 
 
Theme 1 
Psychometric properties 
AND Theme 2 
Pain and/or Physical functional Outcome 
measures 
AND Theme 3 
Neuropathic 
Pain 
Clinometric properties OR 
Validity OR 
Reliability OR 
Sensitivity OR 
Responsiveness OR 
Minimal(ly) clinically important 
difference OR 
Minimal(ly) clinically important 
change OR 
Minimum detectable change OR 
Smallest detectable change 
 Visual Analog Scale OR 
Numerical Pain Rating scale OR 
McGill pain rating scale OR 
Pain disability index OR 
Functional component of The Western Ontario 
and McMaster Universities Arthritis Index OR 
Timed scored functional activity OR 
Functional reach test OR 
Timed 9.1 metre to walk OR 
Disability of the arm shoulder and hand 
questionnaire OR 
Ulnar Neuropathy at Elbow questionnaire OR 
Daily activities by Verbal Rating Scale OR 
Function interference by Numerical Rating Scale 
 Pain OR 
Nerve pain OR 
Neuralgia OR 
Neurodynia 
OR 
Neuropathy 
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Table II Summary of included studies 
Reference Participant’s characteristics Outcome measures studied Psychometric properties tested 
Alderson & McGall 
1999 
Carpal Tunnel Syndrome  n= 17 
Gender = 5 M, 12 F 
Alderson-McGall hand function 
questionnaire  
Reliability- Internal consistency, test-retest 
reliability; 
Validity- Convergent validity 
Amirjani et al. 2011 Carpal Tunnel Syndrome  n= 162 
Gender = 120 M, 42 F 
Dellon-modified Moberg pick-up 
test 
Reliability- test-retest reliability; 
Validity- Discriminative validity 
Asad et al. 2010 Type 2 diabetics 
sensorimotor NeP 
n= 60 
Gender = not 
mentioned 
modified Neuropathy Disability 
Score  
Validity- Criterion validity  
Bastyr et al. 2005 Diabetic peripheral NeP n= 205 
Gender = 122 M, 83 F 
Neuropathy Total Symptom Score-
6 
Reliability- Internal consistency, test-retest 
reliability; 
Validity- Construct & Convergent validity, 
Responsiveness 
Bouhassira et al. 
2004 
Peripheral and Central 
NeP 
n= 176 
Gender = 97 M, 79 F 
Neuropathic Pain Symptom 
Inventory 
Reliability- test-retest reliability; 
Validity- Face validity, Structural validity, 
Criterion validity, Convergent validity, Divergent 
validity, Responsiveness 
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Bril & Perkins 2002 Type 1 and 2 diabetic 
NeP 
n= 89 
Gender = 65 M, 24 F 
Toronto Clinical Scoring System Reliability- inter-rater, intra-rater reliability; 
Validity- Construct validity 
Bril et al. 2009 Diabetic sensorimotor 
poly NeP 
n= 65 
Gender = 40 M, 25 F 
modified Toronto Clinical 
Neuropathy Score 
Reliability- Internal consistency, inter-rater, intra-
rater reliability; 
Validity- Criterion validity  
Collins et al. 2008 Complex regional pain 
syndrome-I 
n= 27 
Gender = 5 M, 22 F 
Trauma Related Neuronal 
Dysfunction Symptoms Inventory 
Reliability- test-retest reliability & Measurement 
error 
Coplan et al. 2004 Herpes Zoster n= 121 
Gender = 45 M, 76 F 
Zoster Brief Pain Inventory 
Questionnaire 
Reliability- test-retest reliability; 
Validity- Hypothesis testing 
Cornblath et al. 
1999 
Diabetic poly NeP n= 30 
Gender = 18 M, 12 F 
Total Neuropathy Score Reliability- inter-rater & intra-rater reliability; 
Validity- Construct validity 
Crawford et al. 
2008 
Neuropathic Pain n= 130 
Gender = 70 M, 60 F 
Neuropathic Pain Symptom 
Inventory questionnaire 
Validity- Content validity 
Davidoff et al. 1988 Reflex Sympathetic 
Dystrophy Syndrome 
n= 17 
Gender = 5 M, 12 F 
Visual Analog Scales Validity- Hypothesis testing 
de Andrade et al. 
2011 
Neuropathic Pain n= 94 
Gender = 57 M, 37 F 
Portuguese Neuropathic Pain 
Symptoms Inventory 
Reliability- test-retest reliability; 
Validity- Face validity & Construct validity, 
Responsiveness 
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Dias et al. 2008 Wrist and hand 
disorders due to nerve 
involvement 
n= 26 
Gender = not 
mentioned 
The Patient Evaluation Measure; 
The Michigan Hand Outcome 
Questionnaire; 
The Disabilities of Arm, Shoulder 
and Hand Questionnaire 
Reliability- Internal consistency, test-retest 
Reliability; 
Validity- Construct validity 
Dworkin et al. 2009 Diverse chronic pain 
syndrome; 
Diabetic NeP 
n= 1108 
Gender = 599 M, 509 F 
Short-form McGill Pain 
Questionnaire- 2  
Reliability- Internal consistency; 
Validity- Construct validity, Responsiveness 
Eklund et al. 2009 Charcot-Marie-Tooth 
disease 
n= 20 
Gender = 9 M, 11 F 
The Disabilities of Arm, Shoulder 
and Hand Questionnaire 
Validity- Hypothesis testing 
Erdmann et al. 
2005 
Chronic idiopathic 
demyelinating 
polyneuropathy; 
Multifocal Mono 
neuropathy 
n= 30 
Gender = 17 M, 13 F 
Berg Balance Measure; 
10 meter walk test 
Validity- Hypothesis testing 
Farrar et al. 2010 Diabetic peripheral NeP; 
Fibromyalgia syndrome 
n= 1700 
Gender = 680 M, 1020 F 
0 to 10 Numeric Rating Scale  Validity- Responsiveness 
Farrar et al. 2001 Diabetic peripheral NeP; n= 984 0 to 10 point Pain Intensity Validity- Responsiveness 
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Post Herpetic Neuralgia Gender = 567 M, 417 F Numerical Rating Scale 
Farrell et al. 1996 Post Herpetic Neuralgia n= 31 
Gender = not 
mentioned  
Human Activity Profile  Reliability- Internal consistency; 
Validity- Criterion validity & Hypothesis testing, 
Responsiveness 
Felix & 
Widerstrom-Noga 
2009 
NeP related to Spinal 
Cord Injury 
n= 22 
Gender = 19 M, 3 F 
Quantitative Sensory Testing (cold 
and heat pain thresholds) 
Reliability- inter-rater & test-retest reliability; 
Validity- Construct validity 
Galer & Jensen 
1997 
Post Herpetic Neuralgia; 
Diabetic NeP; 
Peripheral Nerve Injury 
n= 160 (69; 24; 67) 
Gender = not 
mentioned 
The Neuropathic Pain Scale Validity- Hypothesis testing- Discriminative 
validity & Predictive validity 
Geber et al. 2011 Peripheral Nerve lesion; 
Other neuropathies 
n= 60 
Gender = 37 M, 23 F 
Quantitative Sensory Testing (heat, 
cold, mechanical and pressure pain 
threshold) 
Reliability- inter-rater & test-retest reliability 
Graham & Hughes 
2006 
Peripheral NeP n= 65 
Gender = 36 M, 29 F 
12-Item Multiple Sclerosis Walking 
Scale 
Reliability- Internal consistency & test-retest 
reliability; 
Validity- Hypothesis testing 
Graham & Hughes 
2006 
Peripheral NeP n= 100 
Gender = 51:49 
The Overall Neuropathy Limitations 
Scale 
Reliability- Internal consistency, inter-rater, test-
retest reliability; 
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Validity-  Content validity & Construct validity, 
Responsiveness 
Harden et al. 2010 Complex and non-
complex regional pain 
syndrome 
n= 155 
Gender = 68 M, 87 F 
Complex regional pain syndrome 
severity score 
Validity- Concurrent validity  
Helme et al. 1989 Chronic Neuropathic 
Pain due to Post 
Herpetic Neuralgia  
n= 49 
Gender = 10 M, 39 F 
McGill Pain Questionnaire Validity- Concurrent validity 
Jensen et al. 2005 Peripheral NeP n= 133 
Gender = 63 M, 70 F 
The Neuropathic Pain Scale Validity- Responsiveness 
Jensen et al. 2006 Diabetes related foot 
pain 
n= 159 
Gender = 83 M, 76 F 
The Neuropathic Pain Scale Validity- Responsiveness 
Jensen et al. 2006 Carpal Tunnel Syndrome n= 40 
Gender = 12 M, 2 F 
Pain Quality Assessment Scale Validity- Responsiveness 
Jensen et al. 2010 Carpal Tunnel Syndrome n= 100 
Gender = 75 M, 25 F 
Pain Quality Assessment Scale Reliability- Internal consistency; 
Validity- Construct validity 
Kilmer et al. 2000 Hereditary motor and 
sensory NeP 
n= 9 
Gender = 3 M, 6 F 
Work stimulation tasks; 
Hand-held dynamometry 
Reliability- test-retest reliability; 
Validity- Construct validity 
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Lee et al. 2010 Typical & atypical facial 
pain due to Trigeminal 
Neuralgia 
n= 156 
Gender = 58 M, 98 F 
Brief Pain Inventory- Facial Reliability- Internal consistency; 
Validity- Construct validity 
Manor et al. 2008 Peripheral NeP n= 20 
Gender = 8 M, 12 F 
Physical Performance Measures Reliability- test-retest reliability 
Maser et al. 1989 Diabetic neuropathy n= 100 
Gender = 54 M, 46 F 
Quantitative sensory testing 
(thermal sensitivity) 
Reliability- inter-rater reliability 
Melchior & Velema 
2011 
Leprosy related 
Neuropathic Pain 
n= 25 
Gender = not 
mentioned  
Screening of Activity Limitation and 
Safety Awareness Scale 
Validity- Construct validity 
Merkies & Schmitz 
2006 
Guillain Barré 
Syndrome; 
Chronic idiopathic 
demyelinating 
polyneuropathy 
n= 20 
Gender = 12 M, 8 F 
The INCAT Overall Disability Sum 
Score  
Validity- Concurrent validity 
Merkies et al. 2002 Neuropathic Pain n= 113 
Gender = not 
mentioned 
The Overall Disability Sum Score  Reliability- inter-rater & intra-rater reliability; 
Validity- construct validity, Responsiveness 
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Merkies et al. 2000 Neuropathic Pain n= 113 
Gender = not 
mentioned 
Inflammatory Sensory Score Reliability- Internal consistency, inter-rater, intra-
rater reliability; 
Validity- Construct validity, Responsiveness 
Mondelli et al. 
2006 
Ulnar Neuropathy at 
Elbow; 
Carpal Tunnel Syndrome 
n= 292 
Gender = 103 M, 189 F 
Ulnar neuropathy at the elbow 
Questionnaire 
Reliability- Internal consistency & test-retest 
reliability; 
Validity- content validity & construct validity, 
Responsiveness 
Murphy et al. 2011 Charcot-Marie-Tooth 
disease 
n= 34 
Gender = not 
mentioned 
Charcot-Marie-Tooth disease 
neuropathy score- 2 
Reliability- inter-rater & intra-rater reliability 
Novak et al. 2010 Peripheral Nerve injury n= 124 
Gender = 83 M, 41 F 
The Disabilities of Arm, Shoulder 
and Hand Questionnaire  
Reliability- Internal consistency; 
Validity- Construct validity 
Novak et al. 2004 Type 2 diabetic NeP n= 30 
Gender = 10 M, 20 F 
Foot Function Index (pain sub 
scale) 
Reliability- Internal consistency; 
Validity- Hypothesis testing 
Oerlemans et al. 
2000 
Reflex Sympathetic 
Dystrophy Syndrome 
n= 54 
Gender = 10 M, 44 F 
The Radboud skills Questionnaire Reliability- inter-rater & test-retest reliability; 
Validity- Construct validity 
Padua et al. 2008 Charcot-Marie-Tooth 
disease 
n= 211 
Gender = 84 M, 127 F 
Barthel Index; 
Deambulation Index 
Validity- Construct validity 
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Padua et al. 2009 Peripheral Nerve 
disease 
n= 392 
Gender = 218 M, 174 
Italian Neuropathic Pain Symptom 
Inventory 
Reliability- test-retest reliability; 
Validity- Construct validity, Responsiveness 
Perez et al. 2002 Complex regional pain 
syndrome-1 
n= 21 
Gender = 4 M, 17 F 
Walking stairs Questionnaire; 
Questionnaire rising and sitting 
down 
Reliability- test-retest reliability 
Rejas et al. 2008 Neuropathic Pain n= 603 
Gender = 211 M, 392 F 
Sheehan Disability Scale Reliability- Internal consistency; 
Validity- Responsiveness 
Schmader et al. 
2007 
Herpes Zoster n= 165 
Gender = 66 M, 99 F 
Zoster Impact Questionnaire; 
Zoster Brief Pain Inventory 
Validity- Hypothesis testing 
Schreuders et al. 
2008 
Charcot-Marie-Tooth 
disease 
n= 45 
Gender = 25 M, 20 F 
Sensory evaluation with Semmes-
Weinstein Monofilaments  
Validity- Construct validity 
Sezgin et al. 2006 Idiopathic Carpal Tunnel 
Syndrome 
n= 67 
Gender = 5 M, 62 F 
Turkish version of the Boston 
Questionnaire 
Reliability- Internal consistency & test-retest 
reliability; 
Validity- Construct validity 
Shy et al. 2005 Charcot-Marie-Tooth 
disease 
n= 60 
Gender = not 
mentioned 
Charcot-Marie-Tooth disease 
neuropathy score 
Reliability- Inter-rater & intra-rater reliability; 
Validity- Construct validity 
Shy et al. 2008 Charcot-Marie-Tooth n= 72 Charcot-Marie-Tooth disease Validity- Responsiveness 
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disease Gender = 48 M, 24 F Neuropathy Score; 
Neuropathy Impairment Score 
Singleton et al. 
2008 
Diabetic peripheral NeP n= 129 
Gender = not 
mentioned  
The Utah Early Neuropathy Scale Reliability- inter-rater reliability; 
Validity- Criterion validity, Responsiveness 
Smith et al. 2004 Diabetic peripheral NeP n= 57 
Gender = 57 M, 0 F 
Step Activity Monitor Validity- Hypothesis testing 
Solari et al. 2008 Charcot-Marie-Tooth 
disease 
n= 40 
Gender = 21 M, 19 F 
The Overall Neuropathy Limitations 
Scale; 
10 m walk; 
9 hole peg test 
Reliability- inter-rater & intra-rater reliability 
The SALSA Group 
2007 
Leprosy &Diabetes 
related NeP 
n= 568 
Gender = 37.6%; 47% F 
Screening of Activity Limitation and 
Safety Awareness Scale 
Reliability- Internal consistency; 
Validity- Content validity 
Valk et al. 2000 Type I and II Diabetes 
NeP 
n= 78 
Gender = 43 M, 35 F 
The Diabetes symptom checklist-
Type 2 
Reliability- test-retest reliability; 
Validity- Construct validity 
van Schie et al. 
2011 
Diabetic peripheral 
neuropathy 
n= 24 
Gender = 17 M, 7 F 
Step Activity Monitor (4 minute 
walking test) 
Validity- Construct validity & Criterion validity 
VanSwearingen & Facial paralysis n= 46 Facial Disability Index Reliability- Internal Consistency; 
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Brach 1996 Gender = 16 M, 30 F Validity- Construct Validity  
Videler et al. 2008 Hereditary motor and 
sensory type 1a 
neuropathy 
n= 49 
Gender = 21 M, 28 F 
Sollerman Hand function test; 
Functional dexterity test 
Reliability- Internal Consistency & test-retest 
reliability 
Villoria et al. 2011 Chronic Neuropathic 
Pain 
n= 548 
Gender = 209 M, 339 F 
Spanish Neuropathic Pain 
Symptom Inventory 
Reliability- Internal Consistency, test-retest 
reliability; 
Validity- Construct validity 
Zelman et al. 2005 Diabetic Peripheral NeP n= 255 
Gender = 114 M, 131 F  
Brief Pain Inventory- Diabetic 
Peripheral Neuropathy scale 
Reliability- Internal Consistency; 
Validity- Construct validity, Discriminative & 
Criterion validity 
Zimmerman et al. 
2009 
Ulnar nerve injury n= 48 
Gender = not 
mentioned 
The Disabilities of the Arm 
Shoulder and Hand Questionnaire; 
Levine-Katz Questionnaire 
Validity- Criterion validity & Construct  validity 
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Table III The COSMIN checklist with 4-point scale [Terwee 2012] 
Step 1 Evaluated measurement properties in the article: Internal consistency, Reliability; 
relative measures (including test-retest reliability, inter-rater reliability and intra-rater 
reliability), Measurement error; absolute measures 
Content validity (including face validity), Structural validity, Hypothesis testing, Cross-
cultural validity, Criterion validity, Responsiveness and Interpretability 
Step 2 Determining if the statistical method used in the article are based on Classical Test 
Theory (CTT) or Item Response Theory (IRT): Box General requirements for studies 
that applied IRT models: excellent/ good/ fair/ poor 
Step 3 Determining if a study meets the standards for good methodological quality:  
excellent/ good/ fair/ poor 
Step 4 Determining the Generalizability of the results 
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Table IV Summary of identified pain Intensity outcome measures with their published psychometric properties and COSMIN grading 
OMs Reliability COSMIN  Validity: COSMIN  Responsiveness COSMIN 
BPI-
DPN 
Internal consistency: 
Zelman (2005): BPI-DPN showed 
satisfactory unidimensionality both for 
the severity and the interference scales 
(Excellent, α= 0.94) 
excellent Construct validity: 
Zelman (2005): BPI-DPN showed satisfactory construct 
validity for both the severity and the interference 
scales 
fair xx xx 
 Discriminant validity: 
Zelman (2005): Subcomponents of BPI-DPN: the 
severity and the interference scale showed 
satisfactory discriminant validity as both are 
correlated to a different extent with other measures- 
SF-12, and HADS (p< 0.001) 
excellent   
  Criterion validity: 
Zelman (2005): BPI-DPN severity scale showed high 
and significant correlations with SF-12v2, and VRS, r's> 
0.66 at p< 0.001 
poor   
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CRPS 
score 
xx xx Concurrent validity: 
Harden (2010): Higher CRPS scores were significantly 
associated with higher Rand 36 scores (pain intensity, 
worse physical and social functioning, greater role 
limitations due to physical and emotional problems, 
and lower energy and emotional well-being) 
fair xx xx 
dSCT2 test-retest reliability: 
Valk (2000): Satisfactory test-retest 
correlation coefficient: severity of 
sensory alteration (0.89), and 
neuropathic pain (0.85) 
fair Construct validity: 
Valk (2000): dSCT2 showed appropriate correlation 
with almost all nerve function tests 
fair xx xx 
FFI Internal consistency: 
Novak (2004): FFI pain subscale showed 
high unidimensionality (Excellent α= 
0.9752) 
poor Hypothesis testing: 
Novak (2004): FFI pain subscale showed moderate 
correlation with 6 meter walk test (r= -0.449, p< 
0.001) 
fair xx xx 
Italian 
NPSI 
test-retest reliability: 
Padua (2009): Results showed high 
poor Construct validity: 
Padua (2009): I-NPSI scores showed significant 
fair Responsiveness: 
Padua (2009): I-NPSI scores 
fair 
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agreement between I-NPSI scores at 
two different visits  
correlation with DN4, VAS and ID pain changes (p= 
0.001) 
represent reliable 
measurements to assess 
NeP symptoms and 
effectiveness of treatment 
on them 
MPQ xx xx Concurrent validity: 
Helme (1989): MPQ showed a significant correlation 
with VAS (r= 0.67), Word descriptor scale (r= 0.67), 
and ADL measures (r= 0.53, p< 0.001) 
poor xx xx 
mTCNS Internal consistency: 
Bril (2009): mTCNS showed satisfactory 
unidimensionality (Moderate, α= 0.78) 
good Criterion validity: 
Bril (2009): Low but acceptable correlation with TCNS 
(Poor, γ= 0.58) 
excellent xx xx 
inter-rater reliability: 
Bril (2009): Satisfactory ICC scores with 
good reliability (ICC= 0.83, 95% CI) 
good     
intra-rater reliability: 
Bril (2009): Satisfactory correlation with 
good     
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symptom and sensory test (к= 0.55- 
0.73) 
NPS xx xx Hypothesis testing: Descriptive validity- 
Galer (1997): 10 NPS pain descriptors showed minimal 
overlap between most items (γ< 0.50) 
poor Responsiveness: 
Jensen (2005): NPS was 
significantly able to detect 
changes from pre-
treatment to post 
treatment scores 
excellen
t 
   Predictive validity: 
Galer (1997): From 10 NPS pain descriptors, only four 
of descriptors (sharp, cold, sensitive and itchy pain) 
were able to discriminate PHN pain from other 
sources of pain, α= 0.01 level 
poor Jensen (2006): From 10 
NPS pain descriptors, seven 
descriptors (intense, sharp, 
hot, dull, sensitive, 
unpleasant, and deep pain) 
were significantly able to 
pick up changes in score 
after treatment 
poor 
NPSI test-retest reliability: fair Face validity: fair Responsiveness: poor 
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Bouhassira (2004): Satisfactory ICC 
scores with excellent test retest 
reliability (ICC> 0.90) 
Bouhassira (2004): The NPSI was completed 
accurately and appeared to be fully understood, 
notably by elderly subjects 
Bouhassira (2004): Poor 
but acceptable correlations 
with PGIC and CGIC scores 
(ρ= 0:67; and ρ= 0.58) Content validity: 
Crawford (2008): Majority of subjects did not raise any 
concerns with NPSI. Thus no changes to NPSI were 
consistently suggested 
excellent 
Structural validity: 
Bouhassira (2004): Each of five factors of NPSI 
corresponded to a relevant clinical component of NeP 
fair 
Convergent validity: 
Bouhassira (2004): Poor but low correlation with 
global pain intensity measured by a numerical scale 
(ρ= 0.60, p< 0.001) 
fair 
Divergent validity: 
Bouhassira (2004): No correlation with anxiety and 
depression scores measured by HADS (ρ= 0.27; and ρ= 
fair 
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0.32) 
Criterion validity: 
Bouhassira (2004): Lower but acceptable correlations: 
pain with brushing (ρ= 0:70), pain due to pressure (ρ= 
0.73); and pain due to cold (ρ= 0.66) 
fair 
0-10 
NRS 
xx xx xx xx Responsiveness: 
Farrar (2010): On ROC 
analysis a raw change of -
1.74 and a % change of -
27.9% were associated 
with clinically meaningful 
change 
fair 
NTSS-6 Internal consistency: 
Bastyr (2005): NTSS-6 showed 
satisfactory unidimensionality 
(Moderate, α= 0.7) 
poor Construct validity: 
Bastyr (2005): NTSS-6 and NSC scores showed 
moderately positive and significant correlation. (ϒ= 
0.773-0.885, p< 0.001) 
fair Responsiveness: MCIDs 
Bastyr (2005): A change of 
0.97 points showed a 
reasonable change for 
fair 
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7 
 
test-retest reliability: 
Bastyr (2005): Satisfactory ICC scores 
with lower but acceptable test retest 
reliability (Baseline ICC= 0.900, End 
point ICC= 0.903) 
fair Convergent validity: 
Bastyr (2005): NTSS-6 and NSC scores showed poorly 
positive and significant correlation with changes from 
baseline (ϒ= 0.519-0.708, p< 0.001) 
fair minimal improvement.  
0-10 
point 
PI-NRS 
xx xx xx xx Responsiveness: 
Farrar (2001): On ROC 
analysis a raw change of -2, 
-2.5, and -3 were 
associated with least, 
average, and worst pains 
good 
PQAS Internal consistency: 
Jensen (2010): PQAS showed 
satisfactory unidimensionality: Deep 
scale (Moderate α= 0.75), surface scale 
(Poor α= 0.69), and paroxysmal scale 
(Good α= 0.87) 
fair Construct validity: 
Jensen (2010): Three of the PQAS items and scale 
scores showed significant correlation with concurrent 
pain interference on BPI (p< .01) 
fair Responsiveness: 
Jensen (2006): Ten of the 
PQAS descriptor items 
significantly picked up the 
changes in scores after 
treatment (p< .0025)  
poor 
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P-NPSI test-retest reliability: 
de Andrade (2011): Satisfactory ICC 
scores with moderate test retest 
reliability (ICC= 0.7678) 
fair Face validity: 
de Andrade (2011): P-NPSI was filled in less than 8 
minutes by 85% of participants. Prevalence rate= 65% 
poor Responsiveness: 
de Andrade (2011): PV-
NPSI change scores show 
significant correlation with 
P-GIC (Good ρ= 0.727), and 
C-GIC scores (Poor ρ= 
0.645) 
fair 
Construct validity: 
de Andrade (2011): PV-NSSI showed low but 
acceptable correlation with NRS: at first visit (Poor ρ= 
0.40, p< 0.0001), at second visit (Poor ρ= 0.53, p< 
0.0001), and change score (Poor ρ= 0.22, p< 0.0001) 
fair 
QST inter-rater reliability: 
Geber (2011): QST showed significant 
inter-rater reliability, r= 0.83 (range= 
0.56- 0.89, p< 0.01) 
good Construct validity: 
Felix (2009): QST showed significant correlation with 
average thermal pain threshold (r= 0.58 at p< 0.02) 
poor xx xx 
Maser (1989): 81% of inter-observer 
agreement that QST can be used 
adjacent to clinical examination for NeP 
assessment 
fair 
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test-retest reliability: 
Felix (2009): Low but acceptable ICC 
scores: cold, and hot pain (Poor ICCs= 
0.50)  
poor 
Geber (2011): QST showed significant 
test-retest reliability, r= 0.86 (range= 
0.67- 0.93, p< 0.01) 
good 
SESWM xx xx Construct validity: 
Schreuders (2008): SESWM showed low but significant 
correlations with MMT (Poor r= 0.57), RIHM 
dynamometry (Poor r= 0.70), and dexterity (Poor r= 
0.65, p< 0.001) 
fair xx xx 
SF-
MPQ-2 
Internal consistency: 
Dworkin (2009): SF-MPQ-2 showed 
satisfactory unidimensionality: Web 
survey data (Excellent, α= 0.91), and 
clinical trial data (Excellent, α= 0.95) 
excellent Construct validity: 
Dworkin (2009): SF-MPQ-2 scores showed significant 
correlation with rating of pain and sleep interference, 
BPI interference scale sores, the SF- 36 PCS, MCS 
scores, the HADS anxiety and depression subscale 
fair Responsiveness: 
Dworkin (2009): Both total 
and sub-scale scores were 
responsive to changes that 
were meaningful to 
fair 
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10 
 
scores patients 
Spanish 
NPSI 
Internal consistency: 
Villoria (2011): S-NPSI showed 
satisfactory unidimensionality: total 
NPSI score (α> 0.80), and NPSI sub 
scores (α> 0.70) 
excellent Construct validity: 
Villoria (2011): S-NPSI showed acceptable accuracy to 
detect responses of pain as defined by either the 
clinical or the discriminant criteria 
fair xx xx 
test-retest reliability: 
Villoria (2011): Moderate test-retest 
reliability with satisfactory ICC scores 
(0.680- 0.810) 
good 
TCSS Inter-rater reliability: 
Bril (2002): Low but acceptable inter-
rater reliability (6.3%) 
poor Construct validity: 
Bril (2002): TCSS showed poor and inverse correlation 
with SUMAMP and SUMCV (ϒ= 0.424; ϒ= 0.302 at p< 
0.0001; and p= 0.0044) 
good xx xx 
Intra-rater reliability: 
Bril (2002): Moderate and satisfactory 
intra-rater reliability (7.3%) 
poor 
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TNS inter-rater reliability: 
Cornblath (1999): Satisfactory ICC 
scores with excellent inter-rater 
reliability (ICC= 0.938, 95% CIs, p≥ 
0.836) 
fair Construct validity: 
Cornblath (1999): TNS showed significantly high and 
positive correlation with NIS (Good, ρ= 0.89, 95 % CIs) 
& NSS (Good, ρ= 0.86, 95% CIs) 
fair xx xx 
intra-rater reliability: 
Cornblath (1999): Satisfactory ICC 
scores with excellent intra-rater 
reliability (ICC= 0.973, 95% CIs, p≥ 
0.950) 
fair 
TRNDSI test-retest reliability: 
Collins (2008): Satisfactory test-retest 
reliability for CRPS-I and Fibromyalgia 
(Excellent and Good, ICC= 0.93; and 
0.83) 
good xx xx xx xx 
Measurement error: 
Collins (2008): SEM values were small 
good 
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compared with domain sum scores 
(3.5%- 8.3%) 
UENS inter-rater reliability: 
Singleton (2008): UENS showed a 
satisfactory high inter-rater reliability 
(94%) 
poor Criterion validity: 
Singleton (2008): UENS (baseline and changeover 
scores) showed a close correlation with Michigan 
Diabetic Neuropathic scale and Neuropathy 
Impairment Score- Lower Leg (p< 0.001) 
excellent Responsiveness: 
Singleton (2008): UENS 
showed a Good diagnostic 
sensitivity at baseline 
without sacrificing 
specificity 
poor 
VAS xx xx Hypothesis testing: 
Davidoff (1988): The VAS had significant correlations 
with limb volume (r
2
= 0.160), active ROM (upper 
extremity: r
2
= 0.167; lower extremity: r
2
= 0.508)and 
joint pain (r
2
= 0.341) 
poor xx xx 
ZBPI test-retest reliability: 
Coplan (2004): ZBPI showed low but 
acceptable test-retest reliability (Poor, 
ICC= 0.63 b/w 5-7 days; Moderate, ICC= 
good Hypothesis testing: 
Coplan (2004): ZBPI showed satisfactory and 
acceptable correlations with MPQ (24 hours: γ> 0.79 
and for 14-35 days γ> 0.65), ADL (for 14-35 days: γ 
good xx xx 
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0.78 b/w 8-10 days and 11-14 days after 
rash onset) 
>0.52), and QoL (γ= 0.78) 
Schmader (2007): ZBPI showed a significant 
correlation with other domains. Increased composite 
pain and discomfort intensity scores were associated 
with increase in ZBPI ADL interference 
fair 
Abbreviations: ADL= Activities of Daily Living, BPI= Brief Pain Inventory Scale, BPI- DPN= Brief Pain Inventory Scale for Diabetic Peripheral Neuropathy, CGIC= Clinical Global 
Impression of Change, CPD= Chronic pain descriptors, CRPS= Complex Regional Pain Syndrome severity, DN4= Douleur Neuropathique 4, dSCT-2= diabetes Symptom Checklist 
Type-2, FFI= Foot Function Index, HADS= Hospital Anxiety and Depression Scale, QoL= Quality of Life, LANSS= Leeds Assessment of Neuropathic pain Symptoms and signs 
Screening Tool, MCS= Mental Component Summary, MPQ= McGill Pain Questionnaire, mTCNS= modified Toronto Clinical Neuropathy Score, NIS= Neuropathy Impairment 
Score, NPS= The Neuropathic Pain Scale, NPSI= Neuropathic Pain Sensory Inventory, NRS= Numeric Rating Scale, NSC= Neuropathy Symptom and Change score, NSS= 
neuropathy sensory symptoms, NTSS-6= Neuropathy Total Symptom Score-6, PGIC= Patient Global Impression of Change, PI-NRS= Pain Intensity Numeric Rating Scale, P-
NPSI= Portuguese version of the Neuropathic Pain Symptoms Inventory, QST= Quantitative Sensory Testing, RIHM= Rotterdam Intrinsic Hand Myometer, SEM= Standard Error 
of Mean, SESWM= Sensory evaluation with Semmens-Weinstein Monofilaments, SF-MPQ= Short-form McGill Pain Questionnaire, SF-12= The Medical Outcomes Study Short 
Form Health Survey (SF-12), SUMAMP= Sum of lower limb distal amplitude, TCSS= Toronto clinical scoring system, TNS= Total Neuropathy Score, TRNDSI= The Trauma Related 
Neuronal Dysfunction Symptoms Inventory, UENS= The Utah Early Neuropathy Scale, VAS= Visual Analog Scale, VRS= Verbal Rating Scale, xx= not determined, ZBPI= Zoster 
Brief Pain Inventory 
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Table V Summary of identified physical functioning outcome measures with their published psychometric properties and COSMIN grading 
OMs Reliability COSMIN Validity COSMIN Responsiveness  COSMIN 
AMHF
Q 
Internal consistency: 
Alderson (1999): AMHFQ showed 
satisfactory unidimensionality 
(Excellent, α= 0.97) 
poor Convergent validity: 
Alderson (1999): Poor correlation with dynamic two-
point discrimination (ϒ= -0.32), static two-point 
discrimination (ϒ= -0.127), the Valpar upper extremity 
range of motion (ϒ= -0.2388), Pain VAS (ϒ= 0,36), 
functional VAS (ϒ= 0.3688), grip strength (ϒ= 0.3867), 
three point pinch strength (ϒ= 0.295), and lateral 
pinch strength (ϒ= 0.151) 
poor xx xx 
test- retest reliability: 
Alderson (1999): All the items showed 
consistent results with in 95th 
percentile confidence limits (Poor – 
Moderate ICCs) 
poor 
BI xx xx Construct validity: 
Padua (2008): Significant relationship b/w ability to 
walk on toes, strength of lower limbs muscles, 
abnormal stand-up, abnormal Romberg test, tactile 
sensory tests; medium relationship with ability to 
stand up and strength forearm and intrinsic hand 
fair xx xx 
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muscles; and lowest relationship with strength of 
hand intrinsic muscles 
BBM xx xx Hypothesis testing: 
Erdmann (2005): High BBS showed low correlation 
with 10 MWT and SIP68 scores (ρ= -0.76, and ρ= -
0.62) 
fair xx xx 
BPI- 
Facial 
Internal consistency: 
Lee (2010): BPI-Facial showed 
satisfactory unidimensionality: entire 
instrument  (Excellent α= 0.94), 
intensity of pain (Good α= 0.86), 
interference with general activities 
(Good α= 0.89), and interference of 
facial- specific items (Excellent α= 
0.95) 
fair Construct validity: 
Lee (2010): BPI-Facial showed borderline significant 
correlation with NRS: At least amount of pain (1.01, p= 
0.111), and during the week (0.95, p= 0.101) 
fair xx xx 
CMTN
S 
inter-rater reliability: 
Shy (2005): Satisfactory ICC scores 
with excellent inter-rater reliability 
fair Construct validity: 
Shy (2005): CMTNS showed strong and satisfactory 
correlations with Ambulation Index (r= 0.81), Self-
fair Responsiveness: 
Shy (2008): CMTNS can be 
used satisfactorily to detect 
poor 
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(ICC= 0.98, p<0.01) Assessment Questionnaire (r= 0.76), Hand Function 
(r= 0.66), 9 Hole Peg test (r= 0.65), CMTNS ulnar and 
median CMAP amplitudes (r= 0.76, 0.72) and 
Neuropathy Impairment Score (r= 0.96) 
progression of CMT disease 
intra-rater reliability: 
Shy (2005): The scores from intra-
scoring examination did not 
significantly vary on sensory 
evaluation 
fair 
CMTN
S-2 
inter-rater reliability: 
Murphy (2011): Satisfactory ICC scores 
with excellent inter-rater reliability: 
CMTSS2 (ICC= 0.97), and CMTES2 
(ICC= 0.96) 
poor xx xx xx xx 
intra-rater reliability: 
Murphy (2011): Satisfactory ICC scores 
with excellent intra-rater reliability: 
CMTSS2 (ICC= 0.96), and CMTES2 
(ICC= 0.97) 
poor 
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DASH Internal consistency: 
Dias (2008): DASH showed satisfactory 
unidimensionality (Excellent, α= 0.98) 
poor Construct validity: 
Dias (2008): DASH showed no significant correlations 
with Gartland and Worley scores (ϒ= -0.33, 5% level)  
poor xx xx 
Novak (2010): DASH showed 
satisfactory unidimensionality 
(Excellent, α= 0.96) 
poor Zimmerman (2009): DASH showed a significant 
correlation with grip strength (r= -0.53), and pinch 
strength (r= -0.49) 
fair 
test-retest reliability: 
Dias (2008): Lower test retest 
reliability (test-retest differences= -4.7 
to 4.9, 95% CIs, p= 0.02 
poor Novak (2010): DASH showed a positive correlation 
with VAS for pain (Poor, r= 0.51, p< 0.001) 
fair 
 Criterion validity: 
Zimmerman (2009): DASH scores corresponded 
strongly with clinical staging (p< 0.001) 
fair   
  Hypothesis testing: 
Eklund (2009): DASH showed strong relationship b/w 
reduced hand function and upper-limb disability: 
manual dexterity (r= -0.64), finger dexterity (r= 0.83), 
grip strength (r= -0.72), tactile gnosis (r= -0.79), and 
hand function index (r= -0.71) 
poor   
DI xx xx Construct validity: fair xx xx 
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Padua (2008): DI showed a significant relationship b/w 
ability to walk on toes, strength of lower limbs 
muscles, abnormal stand-up, abnormal Romberg test, 
tactile sensory tests; medium relationship with ability 
to stand up and strength forearm and intrinsic hand 
muscles; and lowest relationship with strength of 
hand intrinsic muscles 
DMM
PUT 
test-retest reliability: 
Amirjani (2011): Satisfactory ICC 
scores with excellent test retest 
reliability (ICC= 0.91 at 95% CI, p< 
0.001) 
fair Hypothesis testing: Discriminative validity- 
Amirjani (2011): DMMPUT was significantly able to 
differentiate between impaired hand functions with 
mild, moderate and severe CTS 
fair xx xx 
FDI Internal consistency: 
VanSwearingen (1996): FDI showed a 
satisfactory unidimensionality (Theta 
reliability= 0.88) 
fair Construct validity: 
VanSwearingen (1996): FDI physical function subscale 
showed a good correlation with clinician’s physical 
examination of facial movements 
fair xx xx 
FDT test-retest reliability: 
Videler (2008): Satisfactory ICC scores 
fair xx xx xx xx 
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with good test retest reliability (ICC= 
0.83-0.95, 95% CIs) 
HAP Internal consistency: 
Farrell (1996): HAP showed 
satisfactory unidimensionality 
(Excellent to Moderate α= 0.73- 0.97) 
poor Hypothesis testing: 
Farrell (1996): HAP showed strong relationship with 
both maximum activity score and adjusted activity 
score (Excellent, r= 0.97, p< 0.000) 
fair Responsiveness: 
Farrell (1996): HAP was 
sensitive enough to pick up 
changes in initial scores at the 
time of discharge 
poor 
Criterion validity: 
Farrell (1996): HAP showed strong correlation with 
maximum activity score (Good r= 0.78, p< .000), 
adjusted activity score (Good r= 0.83, p< 0.000), and 
Barthel Index: Self-care (Moderate r= 0.75, p< 0.000), 
mobilising (Poor r= 0.61, p< 0.000) 
good 
INCAT 
ODSS 
xx xx Concurrent validity: 
Merkies (2006): INCAT ODSS showed low but 
significant association with changes in ODSS (Poor r= 
0.66, p= 0.007), Rankin changes (Poor r=0.60, p=0.02), 
and GBS Disability Scale changes (Poor r= 0.56, p= 
0.04) 
poor xx xx 
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ISS Internal consistency: 
Merkies (2000): ISS showed 
satisfactory unidimensionality: First 
visit (Poor α= 0.68), second visit 
(Moderate α=0.73), third visit 
(Moderate α= 0.71), and longitudinal 
(Good α= 0.87) 
poor Construct validity: 
Merkies (2000): ISS showed moderate correlations 
with the additional scales in the stable group (Poor, r= 
0.38- 0.56, p< 0.006) 
fair Responsiveness: 
Merkies (2000): ISS showed 
significant association of 
patient's grading with the 
clinical judgment scores 
during follow up (p< 0.0001) 
poor 
inter-rater reliability: 
Merkies (2000): Satisfactory ICC scores 
with good inter-rater reliability (ICC= 
0.85 to 0.89, p< 0.0001) 
fair 
intra-rater reliability: 
Merkies (2000): Satisfactory ICC scores 
with good intra-rater reliability (ICC= 
0.85 to 0.89, p< 0.0001) 
fair 
LKQ xx xx Criterion validity: 
Zimmerman (2009): LKQ showed a significant 
correlation with DASH: symptom score (r= 0.79), and 
poor xx xx 
Page 56 of 76
Pain Practice
Pain Practice
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
8 
 
function score (r= 0.87, p< 0.001) 
Construct validity: 
Zimmerman (2009): LKQ function and symptom scores 
corresponded strongly with clinical staging (p< 0.001) 
poor 
MHQ Internal consistency: 
Dias (2008): MHQ showed satisfactory 
unidimensionality (Excellent, α= 0.93) 
poor Construct validity: 
Dias (2008): MHQ showed no significant correlations 
with Gartland and Worley scores (ϒ= -0.30, 5% level) 
poor xx xx 
test-retest reliability: 
Dias (2008): Lower test retest 
reliability (test-retest differences= -4.3 
to 2.2, 95% CIs, p= 0.02) 
poor 
mNDS xx xx Criterion validity: 
Asad (2010): mNDS proved 92.31% sensitivity and 47% 
specificity in assessing the sensorimotor neuropathy 
good xx xx 
10-
MWT 
inter-rater reliability: 
Solari (2008): Satisfactory inter-rater 
reliability with ICC= 0.97 (CI= 0.88- 
0.99) 
fair Hypothesis testing: 
Erdmann (2005): High 10 MWT scores correlated 
significantly with high SIP68 scores (ρ= 0.59, p= 0.036) 
poor xx xx 
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intra-rater reliability: 
Solari (2008): Satisfactory intra-rater 
reliability with ICC= 0.96 (CI= 0.87- 
0.99) 
fair 
NHPT inter-rater reliability: 
Solari (2008): Satisfactory inter-rater 
reliability with ICC= 0.95 (CI= 0.89- 
0.97) 
fair xx xx xx xx 
intra-rater reliability: 
Solari (2008): Satisfactory intra-rater 
reliability with ICC= 0.95 (CI= 0.89- 
0.97) 
fair 
NIS xx xx xx xx Responsiveness: 
Shy (2008): NIS can be used 
satisfactorily to detect 
progression of CMT disease 
poor 
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ODSS inter-rater reliability: 
Merkies (2002): Satisfactory ICC scores 
with excellent inter-rater reliability: 
Experienced examiners (ICC= 0.95), 
Variable examiners (ICC= 0.90) 
fair Construct validity: 
Merkies (2002): ODSS showed low correlation with 
MRC (Poor r= 0.45), INCAT sensory sum score (Poor r= 
0.41), and Right & left hand grip strengths (Poor r= 
0.54 & 0.53) 
fair Responsiveness: 
Merkies (2002): Scores 
showed significant association 
with clinical changes during 
follow ups (Poor r= 0.66, p= 
0.008) 
good 
intra-rater reliability: 
Merkies (2002): Satisfactory ICC scores 
with excellent intra-rater reliability: 
Experienced examiners (ICC= 0.95), 
Variable examiners (ICC= 0.93) 
fair 
ONLS Internal consistency: 
Graham (2006): ONLS showed 
satisfactory unidimensionality (Poor, 
α= 0.6) 
fair Content validity: 
Graham (2006): The results showed that ONLS is 
appropriate to use in clinical practice 
fair Responsiveness: 
Graham (2006): ONLS was 
capable enough to capture a 
change in activity measures to 
a similar extent as that of 
ODSS (SRM= 0.76, 95% CIs) 
poor 
inter-rater reliability: 
Graham (2006): Satisfactory ICC 
scores with excellent test retest 
reliability (ICC= 0.97) 
poor Construct validity: 
Graham (2006): ONLS showed a variable correlation 
with ODSS (Excellent, r= 0.97, p<0.001), 10-meter walk 
time (Poor, r= 0.58), and MRC score (Poor, r= -0.62) 
fair 
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Solari (2008) Satisfactory inter-rater 
reliability with weighted kappa for 
arm score= 0.65 (95% CI= 0.44-0.86), 
and weighted kappa for leg score= 
0.63 (95% CI= 0.41- 0.85) 
fair  
intra-rater reliability: 
Solari (2008): Satisfactory intra-rater 
reliability with weighted kappa for 
arm score= 0.75 (95% CI= 0.54-0.96), 
and weighted kappa for leg score= 
0.68 (95% CI= 0.47- 0.90)  
fair   
test-retest reliability: 
Graham (2006): ONLS showed 
acceptable test-retest reliability as 15 
neurologists independently preferred 
ONLS 
poor   
PEM Internal consistency: 
Dias (2008): PEM showed satisfactory 
poor Construct validity: 
Dias (2008): PEM showed no significant correlations 
poor xx xx 
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unidimensionality (Excellent, α= 0.94) with Gartland and Worley scores (ϒ= -0.37, 5% level) 
test-retest reliability: 
Dias (2008): Lower test retest 
reliability (test-retest differences= -9.3 
to 2.3, 95% CIs, p= 0.02) 
poor 
PPMs test-retest reliability: 
Manor (2008): Both 6 minute walk 
test and Timed up and go test showed 
significant reliability (Excellent ICC= 
0.93- 0.99, 95% CIs) 
poor xx xx xx xx 
QRS test-retest reliability: 
Perez (2002): QRS showed satisfactory 
ICC scores with good test-retest 
reliability (range= 0.84- 0.87, p< 0.001) 
poor xx xx xx xx 
RSQ inter-rater reliability: 
Oerlemans (2000): For inter-rater 
reliability the limits of agreement 
between two observers was -0.26 and 
poor Construct validity: 
Oerlemans (2000): For observer A, 11 test categories 
were highly correlated (> 0.80), however for observer 
B, the correlations were lower (but mostly > 0.60) 
poor xx xx 
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0.22 
test-retest reliability: 
Oerlemans (2000): For test-retest 
reliability the limits of agreement 
between observer A (-0.10 and 0.14) 
and observer B (-0.26 and 0.22) was 
very close 
poor 
SALSA Internal consistency: 
The SALSA Collaborative Study Group 
(2007): SALSA showed satisfactory 
unidimensionality: Leprosy group 
(Good, α= 0.897), and diabetes group 
(Good, α= 0.814) 
excellent Construct validity: 
Melchior (2011): SALSA showed low but acceptable 
correlation with NPHT (Moderate r=0.77, p<.0005), 
SHFE (Poor r= 0.66, p<.0005), and FDT (Poor r= 0.54, 
p<.005) 
poor xx xx 
Content validity: 
The SALSA Collaborative Study Group (2007): SALSA 
showed strong relationship to the scores assigned by 
independent experts: Overall (ρ= 0.67), leprosy group 
(ρ= 0.65), and diabetes group (ρ= 0.70) 
excellent 
SAM xx xx Hypothesis testing: poor xx xx 
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Smith (2004): SAM showed a strong correlation with 
physical Function scale, Physical Component Summary 
score, and Vitality scale (p= 0.01); and a weak 
correlation with Bodily Pain and Role Limitation (p= 
0.05) 
SAM 
(4 
mWT) 
xx xx Construct validity: 
van Schie (2011): SAM (4mWT) showed a significant 
correlation with Dutch version of International 
Physical Activity Questionnaire: min/ week (p= 0.49), 
and activity/ week (p= 0.43, p< 0.05) 
poor xx xx 
Criterion validity: 
van Schie (2011): SAM recorded an accuracy of 98.6% 
compared with observer- counted strides 
poor 
SDS Internal consistency: 
Rejas (2008): SDS showed satisfactory 
unidimensionality (Excellent, α= 
0.904) 
poor xx xx Responsiveness: 
Rejas (2008): SDS was 
significantly able to 
differentiate between 
responders and non-
fair 
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responders 
SHFT Internal consistency: 
Videler (2008): SHFT showed excellent 
homogeneity for both dominant 
hands (α= 0.96), and non-dominant 
hands (α= 0.95) 
fair xx xx xx xx 
test-retest reliability: 
Videler (2008): SHFT showed 
satisfactory test-retest reliability with 
good ICC (83- 0.95, 95% CIs) 
fair 
TBQ Internal consistency: 
Sezgin (2006): TBQ showed 
satisfactory unidimensionality: 
symptom severity scale (Good α= 
0.82), and function status scale (Good 
α= 0.88) 
poor Construct validity: 
Sezgin (2006): TBQ showed satisfactory correlations 
with symptoms severity scale (r= 0.73, p< 0.00001); 
moderate and good correlations with subscales of SF-
36- physical functioning (r= 70.55), physical role (r= 
70.54), bodily pain (r= 70.63, p< 0.0001), and 
emotional role (r= 70.40, p< 0.001) 
good xx xx 
test-retest reliability: 
Sezgin (2006): TBQ showed 
fair 
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satisfactory correlation scores with 
acceptable test-retest reliability: 
symptom severity scale (Poor, r= 
0.60), and function status scale 
(Moderate r= 0.77, p= 0.0001) 
UNEQ Internal consistency: 
Mondelli (2006): UNEQ showed 
satisfactory unidimensionality (Good, 
α= 0.87) 
poor Content validity: 
Mondelli (2006): UNEQ showed a satisfactory content 
validity as all the questions were equally distributed 
between the symptoms numbness/tingling and elbow 
pain 
excellent Responsiveness: 
Mondelli (2006): UNEQ 
showed significant 
responsiveness in picking up 
difference in scores at follow 
ups (Good, r=0.85, p<0.001) 
poor 
test-retest reliability: 
Mondelli (2006): Satisfactory ICC 
scores with excellent test retest 
reliability (ICC= 0.97) 
fair Construct validity: 
Mondelli (2006): UNEQ showed satisfactory 
correlations with scores of the clinical (Poor, ρ=0.65) 
and electrophysiological (Poor, ρ=0.35) severity scales 
poor 
Walk-
12 
Internal consistency: 
Graham (2006): Walk-12 showed 
satisfactory unidimensionality 
(Excellent, α= 0.97) 
poor Hypothesis testing: 
Graham (2006): Walk-12 showed strong correlation 
with the SF-36 Physical Function Subscale (r= 20.82), 
the Social Function Component (r= 20.86), Physical 
poor xx xx 
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test-retest reliability: 
Graham (2006): Satisfactory ICC 
scores with excellent test retest 
reliability (ICC= 0.96) 
poor Component Summary Score (r= 20.72) and the lower 
limb section of the ONLS (r= 0.77) 
WSQ test-retest reliability: 
Perez (2002): WSQ showed 
satisfactory ICC scores with moderate 
test-retest reliability (range= 0.78- 
0.87, p< 0.001) 
poor xx  xx  
WST test-retest reliability: 
Kilmer (2000): WST showed 
acceptable test-retest reliability: 
Pronation (Good ICC= 0.88), 
supination (Good ICC= 0.85), push 
(Excellent ICC= 0.96), pull (Excellent 
ICC= 0.93), and lever arm push (Poor 
ICC= 0.67) 
poor Construct validity: 
Kilmer (2000): WST showed strong and positive 
correlations with Hand Held Dynamometry- measured 
peak torque for both dominant and non-dominant 
hands (p< 0.05) 
poor xx  
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ZIQ xx xx Hypothesis testing: 
Schmader (2007): ZIQ showed a significant correlation 
with other domains. Increased composite pain and 
discomfort intensity scores were associated with 
increase in ZIQ ADL interference scores 
fair xx  
Abbreviations: ADL= Activities of Daily Living, AMHFQ= The Alderson-McGall hand function questionnaire, BBM/S= Berg Balance Measure/ Score, BI= Barthel Index, BPI= Brief 
Pain Inventory, CMAP= compound muscle action potential, CMTNS= Charcot-Marie-Tooth disease Neuropathy score, DASH= The Disabilities of Arm, Shoulder and Hand 
Questionnaire, DI= Deambulation Index, DMMPUT= Dellon-modified Moberg pick-up test, FDI= Facial disability Index, FDT= Functional dexterity test, GBS= Guillain Barré 
Syndrome, HADS= Hospital Anxiety and Depression Scale, HAP= Human Activity Profile, ISS= Inflammatory neuropathy Sensory Score, LKQ= Levine-Katz Questionnaire, MHQ= 
The Michigan Hand Outcome Questionnaire, 10-MWT= 10-Meter walking test, mNDS= modified Neuropathy Disability Score, NHPT= Nine-Hole Peg test, NIS= Neuropathy 
Impairment Score, NRS= Numeric Rating Scale, ODSS= The Overall Disability Sum Score, ONLS= The Overall Neuropathy Limitations Scale, PEM= The Patient Evaluation 
Measure, PPMs= Physical Performance Measures (6 minute walk test, Timed up and go test), QRS= Questionnaire rising and sitting down, R36HS= Rand-36 Health Survey, 
RSQ= The Radboud skills Questionnaire, SALSA= Screening of Activity Limitation and Safety Awareness Scale, SAM= Step Activity Monitor, 4mWT= 4 min walk test, SDS= 
Sheehan Disability Scale, SHFT= Sollerman Hand function test, SIP68= Sickness impact profile 68, TBQ= Turkish version of the Boston Questionnaire, UNEQ= Ulnar neuropathy 
at the elbow Questionnaire, VAS= Visual Analog Scale, Walk-12= 12-Item Multiple Sclerosis Walking Scale, WSQ= Walking stairs Questionnaire, WST= Work stimulation tasks 
(knob turn, Linear motion, and Lever arm), xx= not determined, ZIQ= Zoster Impact Questionnaire 
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Table VI Definition of domains, measurement properties, aspects of measurement properties and accepted statistical analyses by COSMIN 
Domain Measureme
nt property 
Aspect of a 
measurement 
property 
Definition Accepted statistical 
analyses 
Interpretation Inappropriate statistical 
analyses 
R
e
l
i
a
b
i
l
i
t
y
 
Internal 
consistency 
 The degree of the 
interrelatedness among the items 
Cronbach’s alpha (α) 
Internal consistency 
coefficient 
α> 0.90: Excellent 
α= 0.81- 0.90: Good 
α> 0.71-0.80: 
Moderate 
α< 0.70: Poor 
Pearson’s correlation 
coefficient 
Spearman’s correlation 
coefficient 
Reliability Intra-rater 
reliability; 
Inter-rater 
reliability; 
test-retest 
reliability 
The proportion of the total 
variance in the measurements 
which is due to ‘true’ differences 
among patients 
Continuous scores: ICC 
Dichotomous/nominal 
scores: Cohen’s kappa 
(К) 
Ordinal scores: 
Weighted kappa 
ICC or К> 0.90: 
Excellent 
ICC or К=0.81-0.90: 
Good 
ICC or К> 0.71-0.80: 
Moderate 
ICC or К< 0.70: Poor 
 
Measuremen
t error 
 The systematic and random error 
of a patient’s score that is not 
attributed to true changes in the 
construct to be measured 
SEM, SDC or LoA   
V
a
l
i
d
i
t
y
 
Content 
validity 
 The degree to which the content 
of a HR-PRO is an adequate 
reflection of the construct to be 
measured 
   
 Face validity The degree to which (the items Requires a subjective   
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of) an instrument indeed looks as 
though they are an adequate 
reflection of the construct to be 
measured 
judgement, thus no 
analytical standards 
are developed 
Construct 
validity 
 The degree to which the scores of 
a HR-PRO are consistent with 
hypotheses (for instance with 
regard to internal relationships, 
relationships to scores of other 
instruments, or differences 
between relevant groups) based 
on the assumption that the HR-
PRO instrument validly measures 
the construct to be measured 
   
 Structural 
validity 
The degree to which the scores of 
a HR-PRO are an adequate 
reflection of the dimensionality of 
the construct to be measured 
Factor analysis   
 Hypotheses 
testing-
Discriminant 
validity; 
Convergent 
validity; 
Divergent 
Idem construct validity Correlation coefficient Positive correlation: 
γ> 0.90: Excellent 
γ= 0.81- 0.90: Good 
γ> 0.71-0.80: 
Moderate 
γ< 0.70: Poor  
Inverse correlation: 
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validity; 
Sensitivity & 
specificity 
 
γ< -0.90: Excellent 
γ= -0.81 to -0.90: 
Good 
γ= -0.71 to -0.80: 
Moderate 
γ>-0.70: Poor 
 Cross-cultural 
validity 
The degree to which the 
performance of the items on a 
translated or culturally adapted 
HR-PRO instrument are an 
adequate reflection of the 
performance of the items of the 
original version of the HR-PRO 
instrument 
Confirmatory factor 
analyses 
Differential item 
functioning analyses 
  
Criterion 
validity 
Concurrent 
validity 
The degree to which the scores of 
an HR-PRO instrument are an 
adequate reflection of a ‘gold 
standard’ 
When both scores are 
continuous: 
Correlation co-
efficient 
When one is 
continuous score and 
other is dichotomous: 
Area under the ROC 
When both scores are 
dichotomous: 
sensitivity & specificity 
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R
e
s
p
o
n
s
i
v
e
n
e
s
s
 
Responsiven
ess 
 The ability of an HR-PRO 
instrument to detect change over 
time in the construct to be 
measured 
When both scores are 
continuous: 
Correlation co-
efficient 
When one is 
continuous score and 
other is dichotomous: 
Area under the ROC 
When both scores are 
dichotomous: 
sensitivity & specificity 
  Effect size 
Standardised response 
mean 
Norman’s 
responsiveness 
coefficient 
Relative efficacy 
statistic 
Guyyatt’s 
responsiveness ratio 
MIC 
Paired t-test 
I
n
t
e
r
p
r
e
t
a
b
i
l
i
t
y
 
  The degree to which one can 
assign qualitative meaning- i.e., 
clinical or commonly understood 
connotations- to an instrument’s 
quantitative scores or change in 
scores 
MIC and MID   
Abbreviations: α= Cronbach’s alpha, HR-PRO= Health related- patient reported outcome, ICC= Intra class correlation coefficient, К= Cohen’s Kappa, LoA= 
Limits of Agreement, MIC= Minimal important change, MID= Minimal important difference, γ= Correlation coefficient, ROC= Receiver operating curve, SDC= 
Smallest Detectable Change, SEM= Standard Error of Measurement 
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1 
 
 
Figure I Flow diagram summarising study selection process 
Records after duplicates removed 
n= (8505) 
Records screened for title 
n= (214) 
Articles assessed for full text 
eligibility (n= 80) 
Records excluded after 
abstract screening 
(n= 134) 
Full-text articles excluded (n=16) 
n= (2) editorial papers; 
n= (2) commentary papers;  
n= (5) cancer pain;  
n= (3) PhD publications; and 
n= (4) full text article not 
available 
Articles assessed for 
methodological quality on 
COSMIN (n= 64) 
‘Pain Intensity’ outcome measures 
identified (n= 24) 
‘Physical Function’ outcome 
measures identified (n= 37)  
Reliability n= 44; and 
Validity n= 49 
Total records identified through database searching 
AMED= 6770, Ovid Medline= 1319, Scopus= 1590, Web of Science= 
921, CINAHL= 313 
n= (10913) 
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Reviewer 1 
COMMENT EXPLAINATION MODIFICATIONS  
(Highlighted text) 
Introduction   
I think it is preferable to avoid using too many abbreviations e.g. PMP and 
OM. 
We note the potential for confusion, 
thanks for this suggestion. 
Necessary amendments on the 
specified pages have been made. 
It would be helpful in the introduction to separate out the two concepts of 1) 
the need to test the psychometric properties of outcome measures-e.g. if 
reliability has been completed did the results indicate that the test is actually 
reliable and therefore could be recommended for use;[ in methods would be 
good if you assessed this also i.e. quality of the results of measurement 
properties] from 2) the methods used to test the psychometric properties 
(e.g. with COSMIN). The objective gets lost within the final paragraph-can I 
suggest you rephrase as an aim and move the detail on COSMIN to your 
methods section. 
Thank you for your comment. We note 
the reviewer’s concern here. And hence 
the required explanation has been added 
as indicated. 
 
Sentences explaining the aims and 
objectives of the study have been 
rephrased. 
 
Method   
Page 4: Line 41 replace ‘has also been activated’ to ‘was activated’; consider 
rephrasing this sentence as it is not very clear. 
Agreed. Corrections have been made in the 
text. 
Check end search date-differs between abstract and methods. Agreed. Corrections have been made in the 
text. 
Please clarify line 56 ‘OMs used in intervention trials….’ with the statement 
on page 5-eligibility criteria which states that cross sectional clinical trials 
We note the potential for confusion. The 
inclusion criteria for this study was the 
The term unnecessary words have 
been deleted to avoid the confusion. 
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(what is this??, can you have a cross sectional intervention trial) and cohort 
studies (so do you mean an uncontrolled intervention study)? 
cross sectional studies and the 
longitudinal cohort studies. 
Page 6: You seem to only describe a method to explore the methodological 
quality of the individual studies; there is no section on how you made a 
judgement on ‘the evidence for the psychometric properties’ as indicated in 
your objective on page 4; and there is no method section to describe how the 
results will be synthesised (so how can you temper the findings on reliability 
with the quality of the study-e.g. the study reports that the measure is very 
reliability but the methodological quality is very low). 
Thanks for this comment. We concur with 
the reviewer’s statement here. 
The required explanation has been 
added under the section of data 
extraction and synthesis. A new 
table- Table VI has been added 
explaining the information of the 
criteria used for synthesizing the 
results of the study. 
Results   
Page 8: It would be very helpful if you were able to add some description in 
the text to summarise the physical function outcomes measures-so were they 
self-report, physical performance, measuring ability e.g. steps versus 
disability.  A similar overview of pain (if possible) would be helpful. 
Agreed. Please see manuscript for suggested 
overview. 
Page 9: It would be important for the reader to know the results of the 
reliability tests as well as the methodological quality of the study which 
reported on these results (this would help inform some of the statements in 
your discussion e.g. page 10, line 53-many OMs seem promising’-on what 
basis?).  So which tests were reliable (need to indicate in your methods how 
you made that judgement). 
Thanks for this suggestion. We concur 
with reviewer’s concern here. 
Table VI has been added to the 
manuscript, explaining about the 
judgement criteria used for the 
studies. 
Line 31-35-can you provide evidence to support your statement that ‘these 
measures have been proven for their PMPs’. 
We note the reviewer’s concern here. Reference has been provided in the 
text along with Table VI. 
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Page 9: It would be helpful to describe in a separate section the results for 
each of COSMIN boxes that you used. 
Considering the magnitude of the 
COSMIN (9 boxes of definitions and 
explanation for each psychometric 
property for each outcome measure) and 
the word limit, explaining about the 
results of the studies in the form of 
paragraph seemed to a mere replication 
of the tables and thus was avoided.  
No modifications made. 
Discussion   
I found the discussion challenging to read as the text of the results did not 
present the results of the psychometric property under test e.g. if reliability 
was being tested was many of the tests were reliable-and then tempering 
these findings by only using results from the higher quality studies-you may 
have done this but it is not explicit to me in your reporting. I think the 
discussion would become more focused if the methods and results were 
expanded as I have suggested. 
We concur with the reviewer’s statement 
here. But considering the word count, 
explaining about the results of the studies 
in discussion seemed to a mere 
replication of the tables and thus was 
avoided. However the important facts 
which lead to the results and needs to be 
highlighted are well explained. 
Necessary modifications have been 
made. The suggestion under the 
methods and results sections have 
also been accepted. 
Reviewer 2 
COMMENT EXPLAINATION MODIFICATIONS  
(Highlighted text) 
Well done. I have annotated the PDF with some minor grammatical errors; 
otherwise, the manuscript is well done. 
Thanks for your feedback. The potential 
grammatical mistakes have been 
Necessary modifications have been 
made in the sections of Abstract, 
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